from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3390/lpqD

LFCtreatmentdescriptionclass of inhibitor

0.171

Amikacinug/mL Amikacintranslation

0.591

Cap5-10ug/mL Capreomycintranslation

0.518

Rox10-50 ug/mL Roxithromycintranslation

0.168

SM2-5 ug/mL Streptomycintranslation

0.362

Tet5-10 ug/mL Tetracyclinetranslation

-0.685

Rif0.2-5ug/mL Rifampicintranscription

-0.431

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.986

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.632

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.753

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.365

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.035

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.473

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.505

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.410

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.479

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.365

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.036

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.490

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.917

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.438

KCN5-20 ug/mL Potassium cyaniderespiration

-0.560

NaN30.2-2 mM Sodium aziderespiration

1.192

Nigericin50 uM Nigericinrespiration

-0.814

TRC10-150 ug/mL Triclosanrespiration

-0.725

TRZ10-25 ug/mL Thioridazinerespiration

-0.759

Valinomycin0.5-10 uM Valinomycinrespiration

1.737

ZnSO42 mM ZnSO4respiration

-1.259

menadione6-10 ug/mL Menadionerespiration

0.669

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.485

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.782

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.769

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.510

NRP_1Non-replicating persistence stage 1dosRassociated

0.347

Amp0.2mg/mL AmpicillincellWall

0.082

Cephalexin20-100 ug/mL CephalexincellWall

0.300

Cerulenin0.32-5 ug/mL CerulenincellWall

0.319

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.511

EMB10-20 ug/mL EthambutolcellWall

0.535

Eta12-40 ug/mL EthionamidecellWall

0.550

INH0.2-0.4 ug/mL IsoniazidcellWall

0.017

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.929

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.658

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.452

BZA0.12 mg/mL BenzamidearomaticAmides

0.016

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.015

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.263

H2O24 mM hydrogen peroxideDNAdamaging

0.098

Levo10 ug/mL LevofloxacinDNAdamaging

0.394

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.734

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.040

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.150

UVUV-irradiationDNAdamaging

-0.448

ARP41-4 ug/mL Antitubercular compound ARP4?

0.957

Antimycin12.5-50 ug/mL Antimycin A?

0.489

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.195

PA_110-50 ug/mL Antitubercular compound PA-1?

0.299

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.562

PA8240.2-2 ug/mL PA-824?

-2.264

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.809

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.561

Verapamil50 uM Verapamil?

0.446

mercaptoethanol2 mM 2-Mercaptoethanol?

0.336

methoxatin10-20 ug/mL Methoxatin?